Opko Competitors
| OPK Stock | USD 1.23 0.02 1.65% |
Opko Health vs Pacira BioSciences Correlation
Very weak diversification
The correlation between Opko Health and PCRX is 0.43 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Opko Health and PCRX in the same portfolio, assuming nothing else is changed.
Moving against Opko Stock
| 0.59 | PYC | Physiomics Plc | PairCorr |
| 0.58 | EQ | Equillium | PairCorr |
| 0.55 | CMB | Cambium Bio | PairCorr |
| 0.53 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.42 | DRTS | Alpha Tau Medical | PairCorr |
Opko Health Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Opko Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Opko and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Opko Health does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Opko Stock performing well and Opko Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Opko Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SANA | 4.45 | (0.14) | 0.00 | 0.02 | 4.83 | 12.59 | 28.66 | |||
| CTEV | 5.10 | (1.28) | 0.00 | (0.51) | 0.00 | 10.44 | 32.04 | |||
| XNCR | 2.74 | (0.34) | 0.00 | (1.33) | 0.00 | 6.33 | 16.84 | |||
| OCS | 1.98 | 0.60 | 0.24 | 2.31 | 1.71 | 5.79 | 16.37 | |||
| PSNL | 4.42 | (0.10) | 0.01 | 0.03 | 5.17 | 12.21 | 28.22 | |||
| NKTR | 4.64 | 0.54 | 0.10 | 0.99 | 4.83 | 8.03 | 44.06 | |||
| TNDM | 2.41 | 0.19 | 0.07 | 0.23 | 2.57 | 6.16 | 14.29 | |||
| LFMD | 3.67 | (1.01) | 0.00 | (0.23) | 0.00 | 8.55 | 28.11 | |||
| DNTH | 2.97 | 0.46 | 0.13 | 1.91 | 2.82 | 8.95 | 23.32 | |||
| PCRX | 2.04 | (0.10) | 0.00 | (0.08) | 0.00 | 3.14 | 14.12 |
Cross Equities Net Income Analysis
Compare Opko Health and related stocks such as Sana Biotechnology, Claritev, and Xencor Inc Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SANA | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (130.8 M) | (278.6 M) | (344.2 M) | (266.4 M) | (283.3 M) | (266.8 M) | (240.1 M) | (252.1 M) |
| CTEV | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 9.7 M | (520.6 M) | 102.1 M | (572.9 M) | (91.7 M) | (1.6 B) | (1.5 B) | (1.4 B) |
| XNCR | (11.2 M) | (11.2 M) | (8.6 M) | (60.3 M) | (16.4 M) | (17.6 M) | 23.6 M | (48.9 M) | (70.4 M) | 26.9 M | (63.5 M) | 82.6 M | (55.2 M) | (126.1 M) | (232.6 M) | (209.4 M) | (198.9 M) |
| OCS | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (14.9 M) | (18.6 M) | (38.7 M) | (88.8 M) | (85.8 M) | (77.2 M) | (81.1 M) |
| PSNL | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (19.9 M) | (25.1 M) | (41.3 M) | (65.2 M) | (113.3 M) | (108.3 M) | (81.3 M) | (73.2 M) | (76.8 M) |
| NKTR | (5.3 M) | (134 M) | (171.9 M) | (162 M) | (53.9 M) | (81.2 M) | (153.5 M) | (96.7 M) | 681.3 M | (440.7 M) | (444.4 M) | (523.8 M) | (368.2 M) | (276.1 M) | (119 M) | (107.1 M) | (112.4 M) |
| TNDM | (25.5 M) | (25.5 M) | (33 M) | (63.1 M) | (79.5 M) | (72.4 M) | (83.4 M) | (73 M) | (122.6 M) | (24.8 M) | (34.4 M) | 15.6 M | (94.6 M) | (222.6 M) | (96 M) | (86.4 M) | (90.7 M) |
| LFMD | (502.9 K) | (502.9 K) | (445.6 K) | (268.3 K) | (460.5 K) | (62 K) | (1.1 M) | (1.2 M) | (1.2 M) | (3.1 M) | (60.5 M) | (60.9 M) | (45.5 M) | (20.6 M) | (18.9 M) | (17 M) | (17.8 M) |
| DNTH | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (35.5 M) | (57.5 M) | (76.8 M) | (74.9 M) | (13.1 M) | (28.5 M) | (43.6 M) | (85 M) | (76.5 M) | (72.6 M) |
| PCRX | (41.9 M) | (43.3 M) | (52.3 M) | (63.9 M) | (13.7 M) | 1.9 M | (37.9 M) | (42.6 M) | (471 K) | (11 M) | 145.5 M | 42 M | 15.9 M | 42 M | (99.6 M) | (114.5 M) | (108.8 M) |
Opko Health and related stocks such as Sana Biotechnology, Claritev, and Xencor Inc Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Opko Health financial statement analysis. It represents the amount of money remaining after all of Opko Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Opko Health Competitive Analysis
The better you understand Opko Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Opko Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Opko Health's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Opko Health Competition Performance Charts
Five steps to successful analysis of Opko Health Competition
Opko Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Opko Health in relation to its competition. Opko Health's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Opko Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Opko Health's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Opko Health, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Opko Health position
In addition to having Opko Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Soft Drinks Thematic Idea Now
Soft Drinks
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Opko Health Correlation with its peers. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.13) | Earnings Share (0.24) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.